Annual revenue:
$42.13B+$8.41B(+24.95%)Summary
- As of today (April 25, 2025), NVO annual revenue is $42.13 billion, with the most recent change of +$8.41 billion (+24.95%) on December 31, 2024.
- During the last 3 years, NVO annual revenue has risen by +$19.73 billion (+88.06%).
- NVO annual revenue is now at all-time high.
Performance
NVO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$12.24B+$1.73B(+16.50%)Summary
- As of today (April 25, 2025), NVO quarterly revenue is $12.24 billion, with the most recent change of +$1.73 billion (+16.50%) on December 31, 2024.
- Over the past year, NVO quarterly revenue has increased by +$2.42 billion (+24.62%).
- NVO quarterly revenue is now at all-time high.
Performance
NVO Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$42.09B+$2.74B(+6.96%)Summary
- As of today (April 25, 2025), NVO TTM revenue is $42.09 billion, with the most recent change of +$2.74 billion (+6.96%) on December 31, 2024.
- Over the past year, NVO TTM revenue has increased by +$4.67 billion (+12.48%).
- NVO TTM revenue is now at all-time high.
Performance
NVO TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVO Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.9% | +24.6% | +12.5% |
| 3 y3 years | +88.1% | +107.7% | +88.1% |
| 5 y5 years | +130.3% | +154.8% | +123.5% |
NVO Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +88.1% | at high | +107.2% | at high | +81.1% |
| 5 y | 5-year | at high | +130.3% | at high | +176.3% | at high | +124.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Novo Nordisk A/S Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $42.13B(+24.9%) | $12.24B(+16.5%) | $42.09B(+7.0%) |
| Sep 2024 | - | $10.51B(+7.0%) | $39.36B(+5.2%) |
| Jun 2024 | - | $9.82B(+3.2%) | $37.42B(+5.3%) |
| Mar 2024 | - | $9.52B(+0.1%) | $35.54B(+5.4%) |
| Dec 2023 | $33.72B(+34.4%) | $9.51B(+10.8%) | $33.71B(+9.4%) |
| Sep 2023 | - | $8.58B(+8.1%) | $30.82B(+8.5%) |
| Jun 2023 | - | $7.94B(+3.1%) | $28.41B(+7.7%) |
| Mar 2023 | - | $7.70B(+16.4%) | $26.38B(+5.4%) |
| Dec 2022 | $25.09B(+12.0%) | $6.61B(+7.2%) | $25.03B(+2.9%) |
| Sep 2022 | - | $6.17B(+4.4%) | $24.31B(+2.2%) |
| Jun 2022 | - | $5.91B(-6.8%) | $23.79B(+2.4%) |
| Mar 2022 | - | $6.34B(+7.5%) | $23.24B(+3.8%) |
| Dec 2021 | $22.40B(+15.2%) | $5.90B(+4.4%) | $22.38B(+3.5%) |
| Sep 2021 | - | $5.65B(+5.5%) | $21.63B(+3.8%) |
| Jun 2021 | - | $5.35B(-2.3%) | $20.84B(+4.6%) |
| Mar 2021 | - | $5.48B(+6.4%) | $19.92B(+2.5%) |
| Dec 2020 | $19.45B(+6.3%) | $5.15B(+6.0%) | $19.44B(+1.8%) |
| Sep 2020 | - | $4.86B(+9.6%) | $19.10B(+1.9%) |
| Jun 2020 | - | $4.43B(-11.4%) | $18.75B(-0.5%) |
| Mar 2020 | - | $5.00B(+4.1%) | $18.84B(+3.0%) |
| Dec 2019 | $18.30B(+3.3%) | $4.81B(+6.5%) | $18.29B(+1.4%) |
| Sep 2019 | - | $4.51B(-0.2%) | $18.03B(+1.0%) |
| Jun 2019 | - | $4.52B(+1.4%) | $17.85B(+0.7%) |
| Mar 2019 | - | $4.46B(-1.9%) | $17.72B(+0.1%) |
| Dec 2018 | $17.71B(+4.2%) | $4.55B(+5.0%) | $17.71B(+0.7%) |
| Sep 2018 | - | $4.33B(-1.4%) | $17.59B(+0.7%) |
| Jun 2018 | - | $4.39B(-1.2%) | $17.47B(+0.9%) |
| Mar 2018 | - | $4.44B(+0.3%) | $17.31B(+2.2%) |
| Dec 2017 | $17.00B(+2.3%) | $4.43B(+5.3%) | $16.95B(+0.8%) |
| Sep 2017 | - | $4.21B(-0.7%) | $16.80B(+0.5%) |
| Jun 2017 | - | $4.23B(+3.9%) | $16.73B(+0.4%) |
| Mar 2017 | - | $4.08B(-4.9%) | $16.66B(+0.3%) |
| Dec 2016 | $16.61B(+3.5%) | $4.29B(+3.8%) | $16.61B(+0.3%) |
| Sep 2016 | - | $4.13B(-0.9%) | $16.56B(+0.8%) |
| Jun 2016 | - | $4.17B(+3.6%) | $16.42B(+1.0%) |
| Mar 2016 | - | $4.02B(-5.0%) | $16.25B(+1.3%) |
| Dec 2015 | $16.06B(+1.4%) | $4.23B(+6.1%) | $16.05B(+0.7%) |
| Sep 2015 | - | $3.99B(-0.4%) | $15.94B(+0.2%) |
| Jun 2015 | - | $4.01B(+5.0%) | $15.91B(+0.2%) |
| Mar 2015 | - | $3.82B(-7.5%) | $15.87B(+0.5%) |
| Dec 2014 | $15.84B(+6.4%) | $4.13B(+4.3%) | $15.79B(+1.1%) |
| Sep 2014 | - | $3.96B(-0.5%) | $15.62B(+2.0%) |
| Jun 2014 | - | $3.97B(+6.4%) | $15.31B(+1.5%) |
| Mar 2014 | - | $3.73B(-5.7%) | $15.08B(+1.3%) |
| Dec 2013 | $14.88B(+10.4%) | $3.96B(+8.6%) | $14.89B(+2.2%) |
| Sep 2013 | - | $3.65B(-2.7%) | $14.57B(+2.2%) |
| Jun 2013 | - | $3.75B(+5.9%) | $14.26B(+2.8%) |
| Mar 2013 | - | $3.54B(-3.0%) | $13.87B(+3.0%) |
| Dec 2012 | $13.47B(+8.7%) | $3.64B(+9.4%) | $13.47B(+2.8%) |
| Sep 2012 | - | $3.33B(-0.9%) | $13.10B(+1.5%) |
| Jun 2012 | - | $3.36B(+7.4%) | $12.91B(+2.2%) |
| Mar 2012 | - | $3.13B(-4.6%) | $12.63B(+2.0%) |
| Dec 2011 | $12.39B(+14.5%) | $3.28B(+4.6%) | $12.38B(+2.9%) |
| Sep 2011 | - | $3.14B(+1.5%) | $12.04B(+3.7%) |
| Jun 2011 | - | $3.09B(+7.3%) | $11.60B(+4.1%) |
| Mar 2011 | - | $2.88B(-1.9%) | $11.15B(+3.1%) |
| Dec 2010 | $10.82B(+13.2%) | $2.94B(+8.7%) | $10.81B(+3.3%) |
| Sep 2010 | - | $2.70B(+2.7%) | $10.47B(+2.9%) |
| Jun 2010 | - | $2.63B(+3.4%) | $10.17B(+2.5%) |
| Mar 2010 | - | $2.54B(-1.9%) | $9.92B(+3.7%) |
| Dec 2009 | $9.56B(+6.3%) | $2.59B(+7.8%) | $9.57B(+3.8%) |
| Sep 2009 | - | $2.40B(+1.1%) | $9.22B(+1.6%) |
| Jun 2009 | - | $2.38B(+8.6%) | $9.08B(+0.6%) |
| Mar 2009 | - | $2.19B(-2.3%) | $9.02B(+0.6%) |
| Dec 2008 | $9.00B(+16.8%) | $2.24B(-0.9%) | $8.97B(+1.2%) |
| Sep 2008 | - | $2.26B(-2.8%) | $8.87B(+3.8%) |
| Jun 2008 | - | $2.33B(+9.1%) | $8.54B(+5.1%) |
| Mar 2008 | - | $2.13B(-0.3%) | $8.12B(+5.3%) |
| Dec 2007 | $7.70B(+18.0%) | $2.14B(+10.4%) | $7.72B(+4.4%) |
| Sep 2007 | - | $1.94B(+1.4%) | $7.39B(+4.3%) |
| Jun 2007 | - | $1.91B(+10.8%) | $7.09B(+4.0%) |
| Mar 2007 | - | $1.73B(-4.9%) | $6.82B(+4.3%) |
| Dec 2006 | $6.53B(+15.9%) | $1.81B(+10.8%) | $6.54B(+5.1%) |
| Sep 2006 | - | $1.64B(-0.2%) | $6.22B(+3.3%) |
| Jun 2006 | - | $1.64B(+13.7%) | $6.02B(+4.2%) |
| Mar 2006 | - | $1.44B(-3.7%) | $5.78B(+2.9%) |
| Dec 2005 | $5.63B(+15.2%) | $1.50B(+4.1%) | $5.61B(+1.2%) |
| Sep 2005 | - | $1.44B(+2.8%) | $5.55B(+4.2%) |
| Jun 2005 | - | $1.40B(+9.2%) | $5.33B(+4.7%) |
| Mar 2005 | - | $1.28B(-10.4%) | $5.09B(+3.8%) |
| Dec 2004 | $4.89B | $1.43B(+17.5%) | $4.90B(+5.8%) |
| Sep 2004 | - | $1.22B(+4.8%) | $4.63B(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $1.16B(+6.0%) | $4.43B(+3.9%) |
| Mar 2004 | - | $1.09B(-5.8%) | $4.26B(+5.3%) |
| Dec 2003 | $4.05B(+26.6%) | $1.16B(+14.5%) | $4.05B(+6.9%) |
| Sep 2003 | - | $1.01B(+2.3%) | $3.79B(+4.4%) |
| Jun 2003 | - | $992.25M(+12.8%) | $3.63B(+10.3%) |
| Mar 2003 | - | $879.28M(-2.3%) | $3.29B(+5.4%) |
| Dec 2002 | $3.20B(+12.3%) | $900.34M(+5.5%) | $3.12B(+3.9%) |
| Sep 2002 | - | $853.80M(+30.8%) | $3.00B(+1.9%) |
| Jun 2002 | - | $652.97M(-8.1%) | $2.94B(-0.7%) |
| Mar 2002 | - | $710.22M(-9.2%) | $2.96B(+1.7%) |
| Dec 2001 | $2.85B(+10.5%) | $781.92M(-1.9%) | $2.91B(+22.2%) |
| Sep 2001 | - | $796.80M(+18.5%) | $2.38B(-30.9%) |
| Jun 2001 | - | $672.68M(+1.7%) | $3.45B(-3.8%) |
| Mar 2001 | - | $661.56M(+161.4%) | $3.59B(-2.1%) |
| Dec 2000 | $2.58B(+9.4%) | $253.11M(-86.4%) | $3.66B(+3.0%) |
| Sep 2000 | - | $1.86B(+129.8%) | $3.56B(+41.4%) |
| Jun 2000 | - | $810.58M(+9.9%) | $2.52B(+4.0%) |
| Mar 2000 | - | $737.25M(+398.7%) | $2.42B(+1.6%) |
| Dec 1999 | $2.36B(+15.6%) | $147.83M(-82.0%) | $2.38B(+2.2%) |
| Sep 1999 | - | $821.66M(+15.0%) | $2.33B(+3.1%) |
| Jun 1999 | - | $714.35M(+2.2%) | $2.26B(+2.1%) |
| Mar 1999 | - | $699.25M(+619.8%) | $2.22B(+4.4%) |
| Dec 1998 | $2.04B(-20.8%) | $97.15M(-87.1%) | $2.12B(-22.2%) |
| Sep 1998 | - | $750.72M(+12.4%) | $2.73B(+4.7%) |
| Jun 1998 | - | $668.15M(+10.4%) | $2.60B(+1.4%) |
| Mar 1998 | - | $605.00M(-13.7%) | $2.57B(+1.2%) |
| Dec 1997 | $2.58B(+0.2%) | $701.25M(+11.8%) | $2.54B(-0.6%) |
| Sep 1997 | - | $627.41M(-0.7%) | $2.55B(-0.3%) |
| Jun 1997 | - | $631.76M(+9.9%) | $2.56B(+1.4%) |
| Mar 1997 | - | $575.07M(-19.7%) | $2.52B(-1.2%) |
| Dec 1996 | $2.57B(+5.0%) | $716.07M(+12.7%) | $2.55B(+4.0%) |
| Sep 1996 | - | $635.32M(+6.3%) | $2.46B(+2.4%) |
| Jun 1996 | - | $597.46M(-1.2%) | $2.40B(-2.2%) |
| Mar 1996 | - | $604.87M(-2.1%) | $2.45B(+1.2%) |
| Dec 1995 | $2.45B(+15.0%) | $617.87M(+6.7%) | $2.42B(+1.2%) |
| Sep 1995 | - | $578.90M(-11.3%) | $2.40B(+1.3%) |
| Jun 1995 | - | $652.47M(+13.4%) | $2.36B(+5.7%) |
| Mar 1995 | - | $575.16M(-2.3%) | $2.24B(+5.3%) |
| Dec 1994 | $2.13B(+4.9%) | $588.55M(+7.4%) | $2.13B(-2.0%) |
| Sep 1994 | - | $547.95M(+4.2%) | $2.17B(+4.0%) |
| Jun 1994 | - | $525.81M(+13.5%) | $2.09B(+2.0%) |
| Mar 1994 | - | $463.15M(-26.8%) | $2.04B(+2.3%) |
| Dec 1993 | $2.03B(+14.6%) | $633.01M(+36.2%) | $2.00B(+9.9%) |
| Sep 1993 | - | $464.66M(-4.0%) | $1.82B(+0.6%) |
| Jun 1993 | - | $484.02M(+15.9%) | $1.81B(+1.9%) |
| Mar 1993 | - | $417.53M(-7.9%) | $1.78B(-0.3%) |
| Dec 1992 | $1.77B(+15.0%) | $453.56M(-0.2%) | $1.78B(-0.8%) |
| Sep 1992 | - | $454.35M(+0.8%) | $1.80B(+5.8%) |
| Jun 1992 | - | $450.60M(+6.3%) | $1.70B(+7.1%) |
| Mar 1992 | - | $423.75M(-9.3%) | $1.58B(+2.4%) |
| Dec 1991 | $1.54B(+14.2%) | $467.25M(+31.5%) | $1.55B(+4.3%) |
| Sep 1991 | - | $355.38M(+5.1%) | $1.48B(+1.5%) |
| Jun 1991 | - | $338.30M(-12.5%) | $1.46B(+1.4%) |
| Mar 1991 | - | $386.54M(-4.3%) | $1.44B(+6.6%) |
| Dec 1990 | $1.35B(+29.3%) | $403.94M(+20.9%) | $1.35B(+7.9%) |
| Sep 1990 | - | $334.06M(+5.1%) | $1.25B(+8.7%) |
| Jun 1990 | - | $317.76M(+6.8%) | $1.15B(+7.8%) |
| Mar 1990 | - | $297.53M(-2.4%) | $1.07B(+2.1%) |
| Dec 1989 | $1.04B(+24.5%) | $304.81M(+30.4%) | $1.05B(+6.7%) |
| Sep 1989 | - | $233.75M(-0.0%) | $981.87M(+5.2%) |
| Jun 1989 | - | $233.82M(-15.0%) | $933.24M(+2.3%) |
| Mar 1989 | - | $275.14M(+15.0%) | $912.23M(+10.9%) |
| Dec 1988 | $838.16M(+13.9%) | $239.16M(+29.2%) | $822.23M(+3.5%) |
| Sep 1988 | - | $185.12M(-13.0%) | $794.23M(+0.6%) |
| Jun 1988 | - | $212.81M(+15.0%) | $789.74M(+5.5%) |
| Mar 1988 | - | $185.13M(-12.3%) | $748.69M(+1.2%) |
| Dec 1987 | $735.83M(+41.8%) | $211.16M(+16.9%) | $740.04M(+11.0%) |
| Sep 1987 | - | $180.64M(+5.2%) | $666.80M(+8.3%) |
| Jun 1987 | - | $171.75M(-2.7%) | $615.56M(+6.6%) |
| Mar 1987 | - | $176.49M(+28.0%) | $577.58M(+11.1%) |
| Dec 1986 | $519.04M(+31.2%) | $137.92M(+6.6%) | $519.67M(+5.4%) |
| Sep 1986 | - | $129.40M(-3.3%) | $493.06M(+7.3%) |
| Jun 1986 | - | $133.77M(+12.8%) | $459.60M(+9.2%) |
| Mar 1986 | - | $118.58M(+6.5%) | $421.07M(+6.6%) |
| Dec 1985 | $395.57M(+8.3%) | $111.30M(+16.0%) | $394.99M(+5.4%) |
| Sep 1985 | - | $95.94M(+0.7%) | $374.78M(+1.2%) |
| Jun 1985 | - | $95.24M(+3.0%) | $370.38M(+1.1%) |
| Mar 1985 | - | $92.51M(+1.5%) | $366.30M(+0.1%) |
| Dec 1984 | $365.11M | $91.09M(-0.5%) | $365.94M(+33.1%) |
| Sep 1984 | - | $91.54M(+0.4%) | $274.84M(+49.9%) |
| Jun 1984 | - | $91.16M(-1.1%) | $183.30M(+98.9%) |
| Mar 1984 | - | $92.14M | $92.14M |
FAQ
- What is Novo Nordisk A/S annual revenue?
- What is the all time high annual revenue for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual revenue year-on-year change?
- What is Novo Nordisk A/S quarterly revenue?
- What is the all time high quarterly revenue for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly revenue year-on-year change?
- What is Novo Nordisk A/S TTM revenue?
- What is the all time high TTM revenue for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM revenue year-on-year change?
What is Novo Nordisk A/S annual revenue?
The current annual revenue of NVO is $42.13B
What is the all time high annual revenue for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual revenue is $42.13B
What is Novo Nordisk A/S annual revenue year-on-year change?
Over the past year, NVO annual revenue has changed by +$8.41B (+24.95%)
What is Novo Nordisk A/S quarterly revenue?
The current quarterly revenue of NVO is $12.24B
What is the all time high quarterly revenue for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly revenue is $12.24B
What is Novo Nordisk A/S quarterly revenue year-on-year change?
Over the past year, NVO quarterly revenue has changed by +$2.42B (+24.62%)
What is Novo Nordisk A/S TTM revenue?
The current TTM revenue of NVO is $42.09B
What is the all time high TTM revenue for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM revenue is $42.09B
What is Novo Nordisk A/S TTM revenue year-on-year change?
Over the past year, NVO TTM revenue has changed by +$4.67B (+12.48%)